Hospital de Especialidades Carlos Andrade Marín also known as HCAM or HECAM, is a teaching hospital in Quito, Ecuador, managed by the Instituto Ecuatoriano de Seguridad Social. The hospital is located in the center of Quito. It offers full services to those covered by social security.

During the past decade, Hospital Carlos Andrade Marin conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Carlos Andrade Marin" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Antisoma Research" with 1 trials sponsored, "Complejo Hospitalario Dr. Arnulfo Arias Madrid" with 1 trials sponsored, "Fresenius Kabi" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Carlos Andrade Marin" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Carlos Andrade Marin" are "Acute Respiratory Failure" (1 trials), "B-cell Lymphoma" (1 trials), "Caloric Deficit" (1 trials), "Malnutrition" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Hospital Carlos Andrade Marin" in a lesser frequency.

Most popular intervention types in "Hospital Carlos Andrade Marin" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Amonafide and Cytarabine" (1 trials), "Bevacizumab" (1 trials), "CHOP" (1 trials) and "Daunorubicin and Cytarabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Carlos Andrade Marin" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Carlos Andrade Marin". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital Carlos Andrade Marin, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Carlos Andrade Marin, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".